7Information about supplies

7 Information about supplies

For paragraphs 98AC(4)(a) (under co‑payment data) and 99AAA(8)(b) (claims for payment) of the Act, the information that is to be given to the Secretary by an approved supplier in relation to the supply of a pharmaceutical benefit by the approved supplier is as follows: (a) the approved supplier’s approval number allotted under section 16 of the Regulations; (b) if the approval number is to be given using the manual system and the approved supplier is an approved pharmacist: (i) the pharmacist’s name; and (ii) the address of the premises to which the approval number relates; (c) if the approval number is to be given using the manual system and the approved supplier is an approved medical practitioner: (i) the medical practitioner’s name; and (ii) the address to which the medical practitioner wishes correspondence to be directed; (d) if the approval number is to be given using the manual system and the approved supplier is an approved hospital authority: (i) the approved hospital authority’s name; and (ii) the address of the hospital to which the approval number relates; (e) if the approval number is to be given using the Claims Transmission System—the information required under Schedule 1 to be given in relation to the supply of the pharmaceutical benefit.

Note: Under rule 6, the information is to be given to the Chief Executive Medicare on behalf of the Secretary.